Biblio

Author Title [ Type

] Year

Filters: Author is Simonetta, Federico [Clear All Filters]

Journal Article

Maas-Bauer K, Köhler N, Stell A-V, Zwick M, Acharya S, Rensing-Ehl A, König C, Kroll J, Baker J, Koßmann S, et al. Single-cell Transcriptomics Reveal Different Maturation Stages and Sublineages Commitment of Human Thymic Invariant Natural Killer T cells. J Leukoc Biol. 2023.

Giannotti F, Ortiz CDe Ramón, Simonetta F, Morin S, Bernardi C, Masouridi-Levrat S, Chalandon Y, Mamez A-C. Remission of relapsed/refractory classical Hodgkin lymphoma induced by brentuximab vedotin and pembrolizumab combination after allogeneic hematopoietic stem cell transplantation: a case report. Front Immunol. 2024;15:1360275.

Ramos TLopes, Bolivar-Wagers S, Jin S, Thangavelu G, Simonetta F, Lin P-Y, Hirai T, Saha A, Koehn BH, Su LL, et al. Prevention of acute GVHD disease using an orthogonal IL-2/IL-2Rβ system to selectively expand regulatory T-cells in vivo. Blood. 2022.

Bernardi C, Charvet C, Zeiser R, Simonetta F. GM-CSF in Allogenic Hematopoietic Stem Cell Transplantation: from Graft-versus-Host Disease to Graft-versus-Tumor effect. Transplant Cell Ther. 2024.

Marone R, Landmann E, Devaux A, Lepore R, Seyres D, Zuin J, Burgold T, Engdahl C, Capoferri G, Dell'Aglio A, et al. Epitope-engineered human hematopoietic stem cells are shielded from CD123-targeted immunotherapy. J Exp Med. 2023;220(12).

Chalandon Y, Mamez A-C, Giannotti F, Beauverd Y, Dantin C, Mahne E, Mappoura M, Bernard F, Ortiz Cde Ramon, Stephan C, et al. DEFIBROTIDE SHOWS EFFICACY IN THE PREVENTION OF SINUSOIDAL OBSTRUCTION SYNDROME AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: A RETROSPECTIVE STUDY ON 237 PATIENTS. Transplant Cell Ther. 2022.

Sollet ZCalderin, Schäfer A, Ferrari-Lacraz S, Masouridi-Levrat S, Mamez A-C, Pradier A, Simonetta F, Chalandon Y, Villard J, Buhler S. CMV serostatus and T-cell repertoire diversity 5 years after allogeneic hematopoietic stem cell transplantation. Leukemia. 2023.